Filing Details

Accession Number:
0000899243-22-001650
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-11 21:11:24
Reporting Period:
2022-01-11
Accepted Time:
2022-01-11 21:11:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1827087 Vigil Neuroscience Inc. VIGL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1826967 Stefan Vitorovic Vigil Neuroscience, Inc.
1 Broadway, 7Th Floor, Suite 07-300
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-11 3,333,245 $0.00 3,333,245 No 4 C Indirect By Vida Ventures III, L.P.
Common Stock Acquisiton 2022-01-11 7,684 $0.00 7,684 No 4 C Indirect By Vida Ventures III-A, L.P.
Common Stock Acquisiton 2022-01-11 1,671,148 $14.00 5,004,393 No 4 P Indirect By Vida Ventures III, L.P.
Common Stock Acquisiton 2022-01-11 3,852 $14.00 11,536 No 4 P Indirect By Vida Ventures III-A, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Vida Ventures III, L.P.
No 4 C Indirect By Vida Ventures III-A, L.P.
No 4 P Indirect By Vida Ventures III, L.P.
No 4 P Indirect By Vida Ventures III-A, L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2022-01-11 9,243,756 $0.00 3,333,245 $0.00
Common Stock Series B Preferred Stock Disposition 2022-01-11 21,310 $0.00 7,684 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 11, 2022 and had no expiration date.
  2. The shares are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C. ("Vida III GP") is the general partner of of Vida III. The Reporting Person is a managing member of Vida III GP and disclaims beneficial ownership of the shares held directly by Vida III, except to the extent of his pecuniary interest therein, if any.
  3. The shares are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of of Vida III-A. The Reporting Person is a managing member of Vida III GP and disclaims beneficial ownership of the shares held directly by Vida III-A, except to the extent of his pecuniary interest therein, if any.
  4. On January 11, 2022, Vida III purchased 1,671,148 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.
  5. On January 11, 2022, Vida III-A purchased 3,852 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.